Published in Proc Natl Acad Sci U S A on April 19, 2004
Effect of Fasting on the NLRP3 Inflammasome | NCT02122575
Effect of Fasting and Refeeding on T-cell Fate | NCT02719899
Extending healthy life span--from yeast to humans. Science (2010) 12.12
An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol (2007) 5.48
Calories do not explain extension of life span by dietary restriction in Drosophila. PLoS Biol (2005) 4.30
SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (2007) 3.94
Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med (2007) 3.92
Ageing and neuronal vulnerability. Nat Rev Neurosci (2006) 3.36
To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun (2009) 3.00
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res (2008) 2.97
Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell (2008) 2.87
Caloric restriction in humans. Exp Gerontol (2007) 2.66
Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med (2006) 2.32
One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci (2006) 2.31
A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr (2007) 2.16
Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol (2008) 2.10
Validation of anti-aging drugs by treating age-related diseases. Aging (Albany NY) (2009) 2.01
Does caloric restriction extend life in wild mice? Aging Cell (2006) 1.99
Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol (2008) 1.93
Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci (2010) 1.82
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci (2010) 1.80
Calorie restriction and sirtuins revisited. Genes Dev (2013) 1.79
Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circ Res (2008) 1.75
Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) (2009) 1.71
Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev (2009) 1.69
Calorie restriction and prevention of age-associated chronic disease. FEBS Lett (2011) 1.69
Sirtuin 1 in lipid metabolism and obesity. Ann Med (2011) 1.65
The role of sirtuins in the control of metabolic homeostasis. Ann N Y Acad Sci (2009) 1.62
The intersection between aging and cardiovascular disease. Circ Res (2012) 1.61
Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis (2008) 1.58
The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev (2009) 1.57
SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus. J Neurosci (2010) 1.51
Atherosclerosis, cholesterol, nutrition, and statins--a critical review. Ger Med Sci (2007) 1.49
Prior Dietary Practices and Connections to a Human Gut Microbial Metacommunity Alter Responses to Diet Interventions. Cell Host Microbe (2016) 1.43
Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes. Antioxid Redox Signal (2010) 1.42
Genome-environment interactions that modulate aging: powerful targets for drug discovery. Pharmacol Rev (2011) 1.42
mTOR signaling for biological control and cancer. J Cell Physiol (2013) 1.40
Dietary approaches that delay age-related diseases. Clin Interv Aging (2006) 1.37
Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun (2013) 1.36
Caloric restriction: powerful protection for the aging heart and vasculature. Am J Physiol Heart Circ Physiol (2011) 1.35
Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem J (2006) 1.30
Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation. Pharmacol Res (2009) 1.27
Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates. Exp Gerontol (2009) 1.26
Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond) (2013) 1.23
AMP-activated protein kinase and FoxO transcription factors in dietary restriction-induced longevity. Ann N Y Acad Sci (2009) 1.22
The caloric restriction paradigm: implications for healthy human aging. Am J Hum Biol (2012) 1.22
Comparative analysis of microarray data identifies common responses to caloric restriction among mouse tissues. Mech Ageing Dev (2007) 1.22
Mammalian sirtuins and energy metabolism. Int J Biol Sci (2011) 1.17
Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging (2008) 1.17
The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb Exp Pharmacol (2011) 1.16
Optimal body weight for health and longevity: bridging basic, clinical, and population research. Aging Cell (2014) 1.16
Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol (2008) 1.15
Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings. Nutr J (2011) 1.14
Calorie restriction and bone health in young, overweight individuals. Arch Intern Med (2008) 1.14
Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res (2011) 1.14
Bioenergetics and permeability transition pore opening in heart subsarcolemmal and interfibrillar mitochondria: effects of aging and lifelong calorie restriction. Mech Ageing Dev (2009) 1.13
Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell (2013) 1.11
Metabotyping of long-lived mice using 1H NMR spectroscopy. J Proteome Res (2012) 1.11
Will calorie restriction work in humans? Aging (Albany NY) (2013) 1.11
Mitochondrial longevity pathways. Biochim Biophys Acta (2011) 1.11
Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions. Oncotarget (2012) 1.11
Caloric restriction may reverse age-related autonomic decline in humans. Aging Cell (2012) 1.10
Skeletal muscle transcriptional coactivator PGC-1α mediates mitochondrial, but not metabolic, changes during calorie restriction. Proc Natl Acad Sci U S A (2012) 1.10
Levelling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health (2010) 1.06
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. Diabetes Metab J (2013) 1.05
Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp Gerontol (2008) 1.05
The aging process and potential interventions to extend life expectancy. Clin Interv Aging (2007) 1.05
Metabolic characteristics of long-lived mice. Front Genet (2012) 1.04
Effects of caloric restriction on cardiovascular aging in non-human primates and humans. Clin Geriatr Med (2009) 1.03
Long-term effects of caloric restriction or exercise on DNA and RNA oxidation levels in white blood cells and urine in humans. Rejuvenation Res (2008) 1.02
Mitochondria, endothelial cell function, and vascular diseases. Front Physiol (2014) 1.02
Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS). Dose Response (2014) 1.00
Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci (2013) 1.00
Renal protective effects of resveratrol. Oxid Med Cell Longev (2013) 0.99
Perspectives of Targeting mTORC1-S6K1 in Cardiovascular Aging. Front Physiol (2012) 0.97
The role of autophagy in vascular biology. Circ Res (2015) 0.96
Calorie restriction enhances T-cell-mediated immune response in adult overweight men and women. J Gerontol A Biol Sci Med Sci (2009) 0.96
Nrf2 activation as target to implement therapeutic treatments. Front Chem (2015) 0.96
Could Sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions? Age (Dordr) (2009) 0.95
Calorie restriction: what recent results suggest for the future of ageing research. Eur J Clin Invest (2010) 0.95
Calorie restriction and stroke. Exp Transl Stroke Med (2011) 0.95
Endocrine alterations in response to calorie restriction in humans. Mol Cell Endocrinol (2008) 0.95
Drivers of age-related inflammation and strategies for healthspan extension. Immunol Rev (2015) 0.94
Reduced energy intake: the secret to a long and healthy life? IBS J Sci (2007) 0.93
SIRT1 and caloric restriction: an insight into possible trade-offs between robustness and frailty. Curr Opin Clin Nutr Metab Care (2009) 0.93
Caloric restriction: implications for human cardiometabolic health. J Cardiopulm Rehabil Prev (2013) 0.93
Koschei the immortal and anti-aging drugs. Cell Death Dis (2014) 0.93
Aging and dietary restriction effects on ubiquitination, sumoylation, and the proteasome in the heart. Mech Ageing Dev (2008) 0.93
Mitochondria and organismal longevity. Curr Genomics (2012) 0.93
Energetic interventions for healthspan and resiliency with aging. Exp Gerontol (2016) 0.92
Diapause formation and downregulation of insulin-like signaling via DAF-16/FOXO delays axonal degeneration and neuronal loss. PLoS Genet (2012) 0.92
Caloric restriction mimetic 2-deoxyglucose antagonizes doxorubicin-induced cardiomyocyte death by multiple mechanisms. J Biol Chem (2011) 0.92
Growth factors, nutrient signaling, and cardiovascular aging. Circ Res (2012) 0.91
A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr Metab (Lond) (2006) 0.91
Repetitive stimulation of autophagy-lysosome machinery by intermittent fasting preconditions the myocardium to ischemia-reperfusion injury. Autophagy (2015) 0.91
A nutrient-sensitive interaction between Sirt1 and HNF-1α regulates Crp expression. Aging Cell (2011) 0.91
Enhanced phase II detoxification contributes to beneficial effects of dietary restriction as revealed by multi-platform metabolomics studies. Mol Cell Proteomics (2012) 0.91
A single-nucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression. Hum Mol Genet (2010) 0.90
Restriction on an energy-dense diet improves markers of metabolic health and cellular aging in mice through decreasing hepatic mTOR activity. Rejuvenation Res (2015) 0.90
Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives. Clin Geriatr Med (2009) 0.90
Caloric restriction and chronic inflammatory diseases. Oral Dis (2011) 0.90
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation (2001) 14.70
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension (1995) 10.38
Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem (1982) 9.77
Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev (1999) 8.36
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc (1988) 5.39
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med (1997) 4.26
Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med (2002) 4.05
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet (2002) 3.03
Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes (1977) 2.79
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res (1997) 2.72
Mortality from circulatory diseases in Norway 1940-1945. Lancet (1951) 2.64
Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am J Physiol (1994) 2.13
Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation (2002) 1.99
Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol (1985) (2000) 1.81
Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory end points. Am J Physiol (1995) 1.72
Calorie restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. Mech Ageing Dev (1997) 1.47
Atheroprotective effects of high-density lipoproteins. Annu Rev Med (2001) 1.46
Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice. Mech Ageing Dev (2002) 1.46
The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc Natl Acad Sci U S A (1992) 1.45
Ultrasonic evaluation of early carotid atherosclerosis. Stroke (1990) 1.40
Long-term dietary restriction in older-aged rhesus monkeys: effects on insulin resistance. J Gerontol A Biol Sci Med Sci (1995) 1.23
Carotid intima-media thickness and plaque in borderline hypertension. Stroke (1995) 1.17
Mouse models of atherosclerosis. Curr Opin Lipidol (2001) 1.16
The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride. Eur J Clin Nutr (1998) 1.14
Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. J Nutr (2001) 1.11
Caloric restriction increases HDL2 levels in rhesus monkeys (Macaca mulatta). Am J Physiol (1997) 1.10
Changes in plasma lipids and lipoproteins in humans during a 2-year period of dietary restriction in Biosphere 2. Arch Intern Med (1998) 1.03
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med (2003) 9.23
PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol (2005) 5.80
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A (2009) 5.64
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J (2002) 4.75
Physical frailty and body composition in obese elderly men and women. Obes Res (2004) 4.61
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes (2007) 4.28
Aging, adiposity, and calorie restriction. JAMA (2007) 3.95
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med (2010) 3.73
Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes (2008) 3.47
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature (2012) 3.35
Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr (2005) 3.33
Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol (2006) 3.29
Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology (2008) 3.04
Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized, controlled trial. Aesthet Surg J (2013) 3.02
Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler Thromb Vasc Biol (2002) 3.01
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med (2006) 2.94
Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell (2008) 2.87
Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc (2002) 2.80
Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr (2006) 2.76
Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation (2004) 2.73
Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res (2005) 2.72
High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A (2008) 2.65
Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr (2006) 2.57
Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J Biol Chem (2006) 2.51
Energy balance and its components: implications for body weight regulation. Am J Clin Nutr (2012) 2.51
Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation (2010) 2.45
Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: a randomized controlled trial. Arch Intern Med (2006) 2.37
One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci (2006) 2.31
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology (2007) 2.29
Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes (2013) 2.25
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring) (2010) 2.25
Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr (2012) 2.23
A role for the transcriptional coactivator PGC-1alpha in muscle refueling. J Biol Chem (2007) 2.19
Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest (2012) 2.19
Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology (2009) 2.19
A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. Cell Metab (2005) 2.14
Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes (2010) 2.10
Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet (2008) 1.98
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake. Cell Metab (2008) 1.94
Normal adaptations to exercise despite protection against oxidative stress. Am J Physiol Endocrinol Metab (2011) 1.93
Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab (2012) 1.93
Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am J Physiol Endocrinol Metab (2002) 1.88
Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. Am J Physiol Endocrinol Metab (2007) 1.85
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci (2010) 1.80
Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk. Am J Clin Nutr (2006) 1.75
Calcium induces increases in peroxisome proliferator-activated receptor gamma coactivator-1alpha and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem (2007) 1.71
Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss. J Appl Physiol (1985) (2006) 1.68
Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J Lipid Res (2002) 1.67
Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc (2006) 1.66
Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. J Clin Endocrinol Metab (2006) 1.64
Metabolic effects of treatment with atypical antipsychotics. J Clin Psychiatry (2004) 1.63
Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care (2013) 1.63
Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology (2010) 1.62
Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest (2003) 1.62
Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes (2004) 1.60
The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects. J Lipid Res (2011) 1.60
Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation (2011) 1.59
Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci U S A (2007) 1.58
Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr) (2009) 1.57
Exercise induces an increase in muscle UCP3 as a component of the increase in mitochondrial biogenesis. Am J Physiol Endocrinol Metab (2002) 1.57
Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology (2013) 1.57
What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes (2003) 1.56
Assessment of intrahepatic triglyceride content using magnetic resonance spectroscopy. J Cardiometab Syndr (2007) 1.55
Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace (2009) 1.55
Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA (2004) 1.51
Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab (2009) 1.50
A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res (2003) 1.48
Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial. J Gerontol A Biol Sci Med Sci (2005) 1.48
Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr (2003) 1.48
Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes (2007) 1.47
Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab (2013) 1.45
Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr (2008) 1.44
Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial. J Clin Endocrinol Metab (2008) 1.41
Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet (2010) 1.40
Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation. PLoS Biol (2013) 1.40
Celiac disease unmasked after pancreaticoduodenectomy. JPEN J Parenter Enteral Nutr (2005) 1.39
Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) (2009) 1.37
Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial. Diabetes Care (2002) 1.35
Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab (2002) 1.34
Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring) (2009) 1.33
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab (2007) 1.31
Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology (2012) 1.27
Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology (2010) 1.27
Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) (2008) 1.27